What is CBIO's dilution risk score?

CBIO has a latest available DilutionScore record of 52/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for CBIO, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for CBIO?

DilutionWatch tracks 25 SEC filing types for CBIO including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect CBIO shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For CBIO, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for CBIO tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for CBIO. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

CBIO Dilution Risk Score: 52/100 (HIGH)

Score Breakdown

📋 Offering Ability

72

💰 Cash Runway

0

📊 Float Risk

70

⚠️ Warrant Exposure

15

🔄 Convertible Debt

40

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 9%

💰 Capital Raise model 18%

• Active ATM program with $185M remaining capacity

🔔 Track CBIO — Get forecast alerts →

Market Data

Market Cap$569.42M

Shares Outstanding37.14M

Float14.60M

Cash$171.59M

Debt$1.54M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 8.6% shares (2026Q1 vs prior)

60 institutional holders · 27.43M shares

#1 FMR LLC 4.13M shares

#2 BVF INC/IL 2.75M shares

#3 Fairmount Funds Management LLC 2.75M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest3.47M

Days to Cover8.9

% of Float23.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL WARRANT 2025-12-31

424B3 ATM 2026-03-17

EFFECT EFFECT 2026-03-03

424B3 ATM 2026-02-26

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual CBIO Dilution Snapshot

Crescent Biopharma, Inc. (CBIO) has a DilutionScore of 52/100, rated High dilution risk. Score date: August 28, 2026.

Stored ATM program remaining capacity: $185.0M.
Stored outstanding warrants: 553,868.
Recent SEC activity tracked for CBIO: 424B3 on 2026-03-17; EFFECT on 2026-03-03; 424B3 on 2026-02-26.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.